VTAMA

This brand name is authorized in United States.

Active ingredients

The drug VTAMA contains one active pharmaceutical ingredient (API):

1	Tapinarof UNII 84HW7D0V04 - TAPINAROF
	Tapinarof is an aryl hydrocarbon receptor (AhR) agonist. The specific mechanisms by which tapinarof cream exerts its therapeutic action in psoriasis patients are unknown.
	Read more about Tapinarof

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VTAMA Cream	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D05AX07		D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	81672-5051